Skip to main content

Sulfur hexafluoride Pregnancy and Breastfeeding Warnings

Brand names: Lumason

Medically reviewed by Drugs.com. Last updated on Dec 25, 2023.

Sulfur hexafluoride Pregnancy Warnings

This drug should be used only if clearly needed.

US FDA pregnancy category: B

Animal studies have failed to reveal evidence of fetal harm at doses up to 17 times the human dose based on body surface area. There are no controlled data in human pregnancy.

US FDA pregnancy category B: Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women.

See references

Sulfur hexafluoride Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments: The effects in the nursing infant are unknown.

Use of this drug is not a reason to discontinue breastfeeding since drug absorption by the infant is unlikely. Pumping and discarding breast milk one time after receiving this drug is suggested based on the drug's rapid clearance.

See references

See also

References for pregnancy information

  1. Cerner Multum, Inc. "UK Summary of Product Characteristics."
  2. (2014) "Product Information. Lumason (sulfur hexafluoride)." Bracco Diagnostics Inc

References for breastfeeding information

  1. Cerner Multum, Inc. "UK Summary of Product Characteristics."
  2. United States National Library of Medicine (2013) Toxnet. Toxicology Data Network. http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT
  3. (2014) "Product Information. Lumason (sulfur hexafluoride)." Bracco Diagnostics Inc

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer